Results 121 to 130 of about 5,941 (192)

Trends, utilisation and appropriateness of proton pump inhibitor prescriptions among recent initiators: a decade-long analysis of patients with a 1-year washout period (2013-2021). [PDF]

BMJ Open
Liu Y, Zhang N, Ren W, Wang S, Xiang M.
europepmc   +1 more source

QT Prolongation, Ventricular Arrhythmia, and Cardiac Arrest Signals During Ceftriaxone Co-therapy with Individual Proton Pump Inhibitors: A Multidatabase Study. [PDF]

Cardiovasc Toxicol
Chen Y, Gu Q, Zhao M, Zhao A, Kong Z, Shen H, Zhang Y, Wang S, Li L, Xie H, Liu P, Zhang H, Chen D.   +12 more
europepmc   +1 more source

LOw-Dose RAbeprazole Therapy for Reducing Gastrointestinal Events in Patients with High Bleeding Risk (LORA-HBR): A Prospective, Multicenter, Interventional Study. [PDF]

J Clin Med
Kang DO, Choi CU, Lee JH, Hong YJ, Kim JS, Lee HC, Rhew JY, Cho JH, Kim W.   +8 more
europepmc   +1 more source

A Case of Methemoglobinemia Suspected to Be Induced by Rabeprazole. [PDF]

Acute Med Surg
Kawasaki R, Toida C, Kamijo H, Akita M, Hattori M, Ichikawa M, Takayama H, Miyama H, Nitta K, Imamura H.   +9 more
europepmc   +1 more source

Rabeprazole attenuates fibrosis by modulating SMAD3 linker region phosphorylation. [PDF]

Biomed Rep
Li L, Liang Z, Fan L, Cao Y, Tang X, Chen J.   +5 more
europepmc   +1 more source

Real-World Evidence on Different Amoxicillin-Containing Regimens for <i>Helicobacter pylori</i> Treatment in Elderly Patients: Analysis of Efficacy, Safety, and Virulence Gene Association. [PDF]

Antibiotics (Basel)
Chen XL, Gao W, Ye H, Wang ZC, Cheng H, Zhang XZ.   +5 more
europepmc   +1 more source

Immediate-Type PPI Hypersensitivity as a Severe Adverse Drug Reaction: Diagnostic Challenges, Cross-Reactivity, and Real-Life Outcomes. [PDF]

J Clin Med
Kural RF, Tunakan Dalgıç C, Özeke Y, Okan K, Afşin S, Gümüşburun R, Kırdök K, Galata Z, Toksoy Şentürk Mİ, Ateş Ü, Aslan E, Gökmen ENM, Sin AZ.   +12 more
europepmc   +1 more source

Bismuth-Amoxicillin-Vonoprazan Triple, Amoxicillin-Vonoprazan Dual, and Clarithromycin-Based Triple Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Open-Label, Randomized Trial. [PDF]

Helicobacter
Hsu PI, Sheu MJ, Chen CL, Lei WY, Shih CA, Tsay FW, Kao SS, Shie CB, Wu PJ, Kuo CH, Yang JC, Chen KY, Chuah SK, Lee CL, Lee HC, Tai WC, Tsai TJ, Kao JY, Wu DC, Taiwan Acid‐related Disease & Microbiota (TARD‐M) Consortium.   +19 more
europepmc   +1 more source

Impact of Proton Pump Inhibitor Therapy on Bone Mineral Density: An Updated Systematic Review. [PDF]

Cureus
Sundar C, Devang Divakar D, Kumar SS, Manoharan A, Ramalingam S.   +4 more
europepmc   +1 more source

Efficacy of 10 days high-dose and double-dose rabeprazole-based concomitant therapy for Helicobacter pylori eradication among Lebanese population: a pilot randomized controlled trial. [PDF]

BMC Gastroenterol
Elias M, Yazbeck C, Zaarour A, Sleiman V, Sakr N, Raad G, Akiki B.   +6 more
europepmc   +1 more source